{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:24:27Z","timestamp":1789979067607,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijantimicag.2014.12.028","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T18:00:22Z","timestamp":1423677622000},"page":"512-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Joseph L.","family":"Kuti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0891-5520(05)70202-6","article-title":"Intrapulmonary concentrations of antimicrobial agents","volume":"12","author":"Nix","year":"1998","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00133-06","article-title":"Interpretation of antibiotic concentration ratios measured in epithelial lining fluid","volume":"52","author":"Kiem","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/11594090-000000000-00000","article-title":"Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents","volume":"50","author":"Rodvold","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2014.08.014","article-title":"Measuring drug distribution in the critically ill patient","volume":"77","author":"Deitchman","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0205","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/14656566.2012.688952","article-title":"Levofloxacin for the treatment of respiratory tract infections","volume":"13","author":"Torres","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0210","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.46.2.586-589.2002","article-title":"Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and Monte Carlo simulation","volume":"46","author":"Drusano","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.125.3.965","article-title":"Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults","volume":"125","author":"Capitano","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.CCM.0000150265.42067.4C","article-title":"Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia","volume":"33","author":"Boselli","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0225","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijantimicag.2007.05.023","article-title":"Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease","volume":"30","author":"Conte","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0230","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/0091270009355160","article-title":"Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections","volume":"50","author":"Zhang","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pupt.2011.12.007","article-title":"Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis","volume":"25","author":"Nicolau","year":"2012","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0240","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkp301","article-title":"Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs","volume":"64","author":"Crandon","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0245","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1128\/AAC.06121-11","article-title":"Pharmacokinetics and pulmonary disposition of tedizolid and linezolid in a murine pneumonia model under variable conditions","volume":"56","author":"Keel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0924-8579(98)00087-9","article-title":"Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia","volume":"12","author":"Onyeji","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0255","series-title":"Proceedings of the 14th IEEE Symposium on Computer-Based Medical Systems (CBMS)","first-page":"389","article-title":"An adaptive grid non-parametric approach to pharmacokinetic and dynamic (PK\/PD) models","author":"Leary","year":"2001"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1248\/bpb.18.315","article-title":"Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases","volume":"18","author":"Tanigawara","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0270","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.01036-07","article-title":"Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis","volume":"52","author":"Peloquin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0275","series-title":"ADAPT 5 user's guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"D\u2019Argenio","year":"2009"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0280","series-title":"Levaquin\u00ae (levofloxacin) prescribing information","author":"PriCara","year":"2008"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/46.2.319","article-title":"Concentrations of single-dose meropenem (1g iv) in bronchoalveolar lavage and epithelial lining fluid","volume":"46","author":"Allegranzi","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0290","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1378\/chest.119.4.1114","article-title":"Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects","volume":"119","author":"Gotfried","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0295","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.46.5.1475-1480.2002","article-title":"Intrapulmonary pharmacokinetics of linezolid","volume":"46","author":"Conte","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0300","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1128\/AAC.47.8.2450-2457.2003","article-title":"Steady-state and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults","volume":"47","author":"Rodvold","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0305","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.CCM.0000168206.59873.80","article-title":"Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia","volume":"33","author":"Boselli","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijantimicag.2005.08.015","article-title":"Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem","volume":"26","author":"Conte","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0315","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/AAC.05354-11","article-title":"Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers","volume":"56","author":"Housman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0320","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/jac\/dks022","article-title":"Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia","volume":"67","author":"Boselli","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0325","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1592\/phco.22.15.1216.33484","article-title":"Pharmacokinetics and oral levofloxacin in critically ill adults in a medical intensive care unit","volume":"22","author":"Rebuck","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0330","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.45.3.794-799.2001","article-title":"Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model","volume":"45","author":"Xuan","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0335","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.45.10.2793-2797.2001","article-title":"Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections","volume":"45","author":"Ambrose","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0340","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/AAC.00006-09","article-title":"Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets","volume":"53","author":"Louie","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0345","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/AAC.00144-09","article-title":"Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole","volume":"53","author":"Rodvold","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0350","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2014.131","article-title":"Pulmonary penetration of piperacillin and tazobactam in critically ill patients","volume":"96","author":"Felton","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0355","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/AAC.01330-10","article-title":"Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia","volume":"55","author":"Lodise","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.028_bib0360","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1592\/phco.2005.25.10.1310","article-title":"Pharmacokinetics of intravenously administered levofloxacin in men and women","volume":"25","author":"Overholser","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T08:51:02Z","timestamp":1537865462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0924857915000540"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.028","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}